Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society - 1 Apr 2002

Crippin Jeffrey S, McCashland Tim, Terrault Norah, Sheiner Patricia, Charlton Michael R

Abstract excerpt

Decompensated liver disease associated with chronic hepatitis C virus (HCV) infection is the most common indication for liver transplantation. It was shown previously that greater pretransplantation HCV titers are associated with relatively poor patient and graft survival. The tolerability and efficacy of antiviral therapy in patients with decompensated liver disease are not known. We conducted a pilot study to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Administration Schedule
Share to Interferon alpha-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Transplantation

Share to Patient Selection

Share to Pilot Projects

Share to Probability

Share to Ribavirin

Share to Safety

Source

Identifiers

PMID: 11965579
DOI: 10.1053/jlts.2002.31748

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.PMID 11965579Read ↗

Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition.Semantic proximity Read ↗

Treatment of patients with hepatitis C virus on the waiting list.Semantic proximity Read ↗

Twice-Daily Telaprevir for Posttransplant Genotype 1 Hepatitis C Virus: A Prospective Safety, Efficacy, and Pharmacokinetics Study.Semantic proximity Read ↗

Management of hepatitis C after transplantation: a long way from success.Semantic proximity Read ↗

Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients.Semantic proximity Read ↗

Hepatitis C virus in the transplant setting.Semantic proximity Read ↗

Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.Semantic proximity Read ↗

Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study.Semantic proximity Read ↗

Hepatitis C treatment in patients on the liver transplant waiting list.Semantic proximity Read ↗

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.Semantic proximity Read ↗

Splenectomy prior to antiviral therapy in patients with hepatitis C virus related decompensated cirrhosis.Semantic proximity Read ↗

IFN-alpha2b monotherapy in patients with chronic hepatitis C and persistently normal or near normal aminotransferase activity: a randomized, controlled study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.